Insider Transactions in Q4 2023 at Elevance Health, Inc. (ELV)
Insider Transaction List (Q4 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 14
2023
|
Blair Williams Todt EVP, CLO & CAO |
SELL
Open market or private sale
|
Direct |
5,492
-30.5%
|
$2,658,128
$484.02 P/Share
|
|
Dec 14
2023
|
Blair Williams Todt EVP, CLO & CAO |
BUY
Exercise of conversion of derivative security
|
Direct |
5,492
+23.37%
|
$1,708,012
$311.48 P/Share
|
|
Dec 01
2023
|
Blair Williams Todt EVP, CLO & CAO |
SELL
Payment of exercise price or tax liability
|
Direct |
116
-0.92%
|
$56,028
$483.12 P/Share
|
|
Nov 30
2023
|
Ronald W Penczek CAO & Controller |
SELL
Open market or private sale
|
Direct |
1,055
-37.12%
|
$501,125
$475.17 P/Share
|
|
Nov 01
2023
|
Charles Morgan Kendrick Jr EVP & President, Commercial |
SELL
Payment of exercise price or tax liability
|
Direct |
79
-0.52%
|
$35,234
$446.66 P/Share
|
|
Nov 01
2023
|
Peter D Haytaian EVP & Pres Carelon & CarelonRx |
SELL
Payment of exercise price or tax liability
|
Direct |
154
-0.86%
|
$68,684
$446.66 P/Share
|
|
Oct 24
2023
|
Ronald W Penczek CAO & Controller |
SELL
Open market or private sale
|
Direct |
64
-2.2%
|
$29,056
$454.35 P/Share
|
|
Oct 02
2023
|
Mark Kaye EVP & CFO |
BUY
Grant, award, or other acquisition
|
Direct |
20,276
+29.7%
|
-
|